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lesions are most likely due to abnormal products produced by tumor cells although the exact pathogenesis is unclear. The treatment of these cancer-associated glomerulopathies is primarily targeted at treating the underlying malignancy.
Myeloproliferative disorders include chronic myelogenous leukemia, polycythemia Vera (PCV), and essential thrombocythemia.
Among the myeloproliferative neoplasms, PCV, essential thrombocythemia, and primary myelofibrosis are associated with focal segmental glomerulosclerosis. Glomerular disorders associated with myeloproliferative disorders are usually late complications and tend to have a poor renal prognosis. Failure to recognize paraneoplastic glomerulonephritis can lead to undue delay in initiating anticancer medications.
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